Skip to Content

Join the 'Gonococcal Infection - Uncomplicated' group to help and get support from people like you.

Gonococcal Infection - Uncomplicated News

Related terms: Gonorrhea

Drug-Resistant Gonorrhea a Growing U.S. Threat: CDC

Posted 9 days ago by Drugs.com

WEDNESDAY, Sept. 21, 2016 – Gonorrhea appears to be developing resistance to the two antibiotics that constitute the last available treatment option for the sexually transmitted bacteria, U.S. health officials announced Wednesday. Gonorrhea samples taken last spring from seven patients in Honolulu showed resistance to azithromycin at dramatically higher levels than typically seen in the United States, the U.S. Centers for Disease Control and Prevention reported at its STD Prevention Conference in Atlanta. Five of the samples also showed increased resistance to ceftriaxone, the antibiotic given alongside azithromycin in the dual regimen recommended by the CDC. This is the first cluster of cases to show increased resistance to both azithromycin and ceftriaxone, said Dr. Jonathan Mermin, director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Data ... Read more

Related support groups: Azithromycin, Sexually Transmitted Diseases, Zithromax, Zithromax Z-Pak, Gonococcal Infection - Uncomplicated, Z-Pak, Azasite, Azithromycin Dose Pack, Zithromax TRI-PAK, Gonococcal Infection - Disseminated, Zithromax IV, Gonococcal Infection, Azithromycin/Trovafloxacin, Zmax

U.S. Cases of Drug-Resistant Gonorrhea Rise Fourfold in One Year

Posted 15 Jul 2016 by Drugs.com

THURSDAY, July 14, 2016 – Antibiotic-resistant cases of the sexually transmitted illness gonorrhea have more than quadrupled in the United States. This new data, from the U.S. Centers for Disease Control and Prevention, should serve as a warning that "the future of current treatment options may be in jeopardy," the agency said in a news release issued Thursday. "The confluence of emerging drug resistance and very limited alternative options for treatment creates a perfect storm for future gonorrhea treatment failure in the U.S.," said Dr. Jonathan Mermin, who directs the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and Tuberculosis Prevention. "History shows us that bacteria will find a way to outlast the antibiotics we're using to treat it," Mermin said. "We are running just one step ahead in order to preserve the remaining treatment option for as long as possible." For ... Read more

Related support groups: Sexually Transmitted Diseases, Methicillin-Resistant Staphylococcus Aureus Infection, Gonococcal Infection - Uncomplicated, Gonococcal Infection - Disseminated, Gonococcal Infection

U.K. Case of Throat Gonorrhea Resists Antibiotics

Posted 23 Jun 2016 by Drugs.com

THURSDAY, June 23, 2016 – In an alarming development, British public health experts have confirmed a case of throat gonorrhea that proved untreatable with the standard antibiotic regimen. The patient, a heterosexual man who had just returned to the United Kingdom from Japan, wasn't cured by a pair of antibiotics used as the first-line gonorrhea treatment in many countries, including the United States. "This case highlights that gonorrhea may become untreatable due to antimicrobial resistance," warned Gwenda Hughes, section head of sexually transmitted infections at Public Health England. "Despite successful treatment of this case with higher doses of antibiotics, this approach to treatment would only be an interim solution," noted Hughes, who was not involved with the new study. "Higher-dose treatments are not suitable for all patients, and resistance to higher doses is likely to ... Read more

Related support groups: Azithromycin, Sexually Transmitted Diseases, Zithromax, Rocephin, Zithromax Z-Pak, Gonococcal Infection - Uncomplicated, Ceftriaxone, Z-Pak, Azasite, Azithromycin Dose Pack, Zithromax TRI-PAK, Gonococcal Infection - Disseminated, Zithromax IV, Gonococcal Infection, Azithromycin/Trovafloxacin, Zmax, Trobicin, Ceftriaxone/Lidocaine, Spectinomycin

Antibiotics Overprescribed for Possible STDs: Study

Posted 9 Jun 2016 by Drugs.com

THURSDAY, June 9, 2016 – Three-quarters of emergency room patients who received antibiotics to treat suspected sexually transmitted diseases (STDs) tested negative for the infections, a new study showed. "We have to find the appropriate balance between getting people tested and treated for STDs, but not prescribing antibiotics to patients who don't need them," said researcher Karen Jones, an infection preventionist at St. John Hospital & Medical Center in Detroit. Genital cultures are often collected from patients with possible symptoms of STDs, but results are not immediately available, the investigators noted. For the study, the researchers examined the medical records of more than 1,100 patients who underwent STD testing in the emergency room. Forty percent were treated with antibiotics for suspected gonorrhea and/or chlamydia. Of those, more than 75 percent ended up testing ... Read more

Related support groups: Sexually Transmitted Diseases, Chlamydia Infection, Gonococcal Infection - Uncomplicated, Gonococcal Infection - Disseminated, Gonococcal Infection

CDC: Too Few Schools Teach Prevention of HIV, STDs, Pregnancy

Posted 9 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 9, 2015 – Too few U.S. schools teach students how to protect themselves from HIV and other sexually transmitted diseases, how to prevent pregnancy, and other important sexual health information, federal officials reported Wednesday. In most of the country, fewer than half of high schools and only one-fifth of middle schools teach all 16 sexual health education topics recommended by the U.S. Centers for Disease Control and Prevention. In 44 states, the proportion of high schools that teach all 16 topics in grades 9, 10, 11 or 12 ranges from 21 percent in Arizona to 90 percent in New Jersey. Only three states – New Hampshire, New Jersey and New York – have more than 75 percent of high schools teaching all of the topics. The proportion of middle schools that teach all 16 topics in grades 6, 7 or 8 ranges from 4 percent in Arizona to 46 percent in North Carolina. No state ... Read more

Related support groups: Birth Control, Contraception, Plan B, Emergency Contraception, Mirena, Sprintec, NuvaRing, Provera, Implanon, Nexplanon, Depo-Provera, Ortho Tri-Cyclen, Tri-Sprintec, Yasmin, Microgestin Fe 1/20, Loestrin 24 Fe, Ortho Evra, Plan B One-Step, TriNessa, Lutera

Syphilis, Gonorrhea, Chlamydia Rates Rising for First Time in Years: CDC

Posted 17 Nov 2015 by Drugs.com

TUESDAY, Nov. 17, 2015 – The number of cases of three key sexually transmitted diseases increased last year for the first time since 2006, concerned U.S. health officials reported Tuesday. In 2014, 1.4 million cases of chlamydia were reported to the U.S. Centers for Disease Control and Prevention – a 2.8 percent increase since 2013. This is the highest number of cases of any STD ever reported to the CDC, the government researchers said in the annual report. Substantial increases were also reported in rates of syphilis (15 percent) and gonorrhea (5 percent). And the syphilis rates were highest among gay and bisexual men, according to the CDC's Sexually Transmitted Disease Surveillance, 2014 report. "In the previous years, we have had some declines in some diseases and increases in others. But, we are concerned about the alarming increases we are seeing in chlamydia, gonorrhea and ... Read more

Related support groups: Sexually Transmitted Diseases, Chlamydia Infection, Syphilis, Gonococcal Infection - Uncomplicated, Gonococcal Infection - Disseminated, Tertiary Syphilis, Gonococcal Infection, Syphilis - Early, Congenital Syphilis, Syphilis - Latent

Gonorrhea Becoming More Resistant to One Antibiotic: CDC

Posted 3 Nov 2015 by Drugs.com

TUESDAY, Nov. 3, 2015 – One of several antibiotic treatment options for the sexually transmitted disease gonorrhea seems to be losing its effectiveness, U.S. health officials warn in a new report. The U.S. Centers for Disease Control and Prevention's latest tracking suggests that although resistance to the antibiotic treatment cefixime went down between 2011 and 2013, it started to creep back up in 2014. The good news is that cefixime isn't usually the first drug of choice for treating gonorrhea infections. The CDC's most recent guidelines for gonorrhea treatment (issued in 2012) recommend only using cefixime when the preferred option – ceftriaxone-based combination therapy – isn't available. And the CDC's new report doesn't indicate any recent waning in the effectiveness of that combination therapy. Still, indications of antibiotic resistance among any gonorrhea treatment is ... Read more

Related support groups: Sexually Transmitted Diseases, Rocephin, Cefixime, Gonococcal Infection - Uncomplicated, Ceftriaxone, Gonococcal Infection - Disseminated, Suprax, Gonococcal Infection, Ceftriaxone/Lidocaine

Gonorrhea Resistant to All But One Antibiotic: CDC

Posted 9 Aug 2012 by Drugs.com

THURSDAY, Aug. 9 – With options shrinking to a single antibiotic that can fight resistant strains of gonorrhea, U.S. health authorities issued revised guidelines for treating the sexually transmitted bacteria on Thursday. The U.S. Centers for Disease Control and Prevention now recommends that the injectable antibiotic Rocephin (ceftriaxone) be the first-line treatment for this sexually transmitted disease, supplanting Suprax (cefixime). Rocephin should be used in combination with one of two oral antibiotics: azithromycin or doxycycline, the CDC stated in the guidelines published in the Aug. 10 issue of the Morbidity and Mortality Weekly Report. Strains of gonorrhea that are resistant to Suprax have increased globally. "We are very concerned about the possibility of the potential for untreatable gonorrhea," said Dr. Robert Kirkcaldy, a medical epidemiologist with the CDC's Division of ... Read more

Related support groups: Sexually Transmitted Diseases, Rocephin, Gonococcal Infection - Uncomplicated, Ceftriaxone, Gonococcal Infection - Disseminated, Gonococcal Infection

Gonorrhea's Growing Resistance to Antibiotics Concerns CDC

Posted 7 Jul 2011 by Drugs.com

THURSDAY, July 7 – Gonorrhea appears to be growing increasingly resistant to drugs called cephalosporins, the only remaining class of antibiotics available to treat the sexually transmitted disease, according to a new report. Researchers analyzed 10 years' worth of gonorrhea samples (isolates) from men in 30 U.S. cities. The samples were collected between January 2000 and June 2010 through the U.S. Centers for Disease Control and Prevention's Gonococcal Isolate Surveillance Project. The analysis revealed an increase in the proportion of samples with elevated minimum inhibitory concentrations (MICs), the lowest concentration of antibiotics needed to halt the growth of gonorrhea bacteria. These increases in MICs suggest a decline in gonorrhea's susceptibility to antibiotics, the researchers explained in a CDC news release. During the study period, the percentage of gonorrhea samples ... Read more

Related support groups: Sexually Transmitted Diseases, Rocephin, Cefixime, Gonococcal Infection - Uncomplicated, Ceftriaxone, Gonococcal Infection - Disseminated, Suprax, Gonococcal Infection

New STD Report Finds Some Progress, High Costs for U.S.

Posted 23 Nov 2010 by Drugs.com

MONDAY, Nov. 22 – The approximately 19 million new sexually transmitted disease (STD) infections that occur each year in the United States cost the health care system about $16.4 billion annually, the U.S. Centers for Disease Control and Prevention said in its annual STD report released Monday. The data for 2009 shows a continued high burden of STDs but there are some signs of progress, according to the report, which focuses on chlamydia, gonorrhea and syphilis. The national rate of reported gonorrhea cases stands at 99 cases per 100,000 people, its lowest level since record keeping started in 1941, and cases are declining among all racial/ethnic groups (down 17 percent since 2006). Since 2006, chlamydia infections have increased 19 percent to about 409 per 100,000 people. However, the report suggests that this indicates more people than ever are being screened for chlamydia, which is ... Read more

Related support groups: HIV Infection, Sexually Transmitted Diseases, Chlamydia Infection, Herpes Simplex - Suppression, Trichomoniasis, Herpes Simplex, Human Papilloma Virus, Condylomata Acuminata, Syphilis, Gonococcal Infection - Uncomplicated, Herpes Simplex, Mucocutaneous/Immunocompromised Host, Herpes Simplex, Mucocutaneous/Immunocompetent Host, Herpes Simplex Encephalitis, Cervical Dysplasia, Gonococcal Infection - Disseminated, Gonococcal Infection, Tertiary Syphilis, Neurosyphilis, Syphilis - Early, Human Papillomavirus Prophylaxis

Ask a Question

Further Information

Related Condition Support Groups

Gonococcal Infection

Related Drug Support Groups

doxycycline, azithromycin, Cipro, ciprofloxacin, Levaquin, Zithromax, levofloxacin, tetracycline, cefuroxime, view more... Rocephin, Doryx, Ceftin, cefixime, ofloxacin, Oracea, ceftriaxone, Monodox, cefpodoxime, Doxy Lemmon, cefotaxime, Vibramycin, Adoxa, Azithromycin Dose Pack, Doxy 100, gatifloxacin, norfloxacin, Floxin, Suprax, Vibra-Tabs, Vantin, Zmax, Noroxin, Cipro XR, Doxy 200, piperacillin, Cefizox, Cipro IV, cefoxitin, bacampicillin, Sumycin 250, Adoxa TT, Oraxyl, Achromycin V, Levaquin Leva-Pak, Floxin IV, Spectrobid, Adoxa CK, Tequin Teqpaq, Mezlin, Acticlate, Penetrex, Ocudox, Morgidox, NicAzel Doxy, Targadox, Avidoxy, Doryx MPC, Mondoxyne NL, Uracil, Sumycin, Zinacef, Periostat, Tequin, Doxy-D, Mefoxin, Claforan, ceftizoxime, enoxacin, mezlocillin, Doxy-Caps, Alodox, Emtet-500, Tetracon, Kefurox, Tetracap, Brodspec, Panmycin, Robitet 500, Ala-Tet, Pipracil